Islet Transplantation
8
0
0
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
25.0%
2 terminated out of 8 trials
66.7%
-19.8% vs benchmark
13%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy
Nephrologic Prognosis 10 Years After Diabetes Cell Therapy
CGM Use in Islet Transplant Recipients
Extended Follow-Up After Islet Transplantation in T1D
Effect of Sitagliptin on Graft Function Following Islet Transplantation
A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell Transplantation
Imaging of Islet Transplantation With PET and MRT
Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts